Multi-vendor laboratory services have proved to be a fast growing and strategic market for analytical instrument companies. Such services not only expand a particular instrument company’s share of an end-user’s service revenues, but also provide greater customer intimacy and an expanded presence in the end-user’s lab. As a result, the breadth of such offerings has […]

As the first company to offer 2.7 µm superficially porous particle columns for HPLC, Advanced Materials Technology (AMT) has quickly grown. Founded as a two-person operation in Delaware in 2005, today, the company employs more than 20 people, including eight scientists in analytical chemistry, chemical engineering and biochemistry. The company exclusively manufactures HPLC columns utilizing […]

In the fiscal year ending September 30, 2011 (FY11), science and engineering (S&E) research space at US universities performing research increased 3.5% to 202.9 million net assignable square feet (NASF), compared with 2009. This is slower growth than the 4.4% increase recorded between FY07 and FY09, but an increase from the 1.5% growth from FY05 […]

Eleven of the 18 companies in the IBO Laboratory Instrument Sales Index reported fourth-quarter 2012 results before this issue’s publication. Including estimates for firms yet to report, fourth-quarter 2012 revenue for the Index improved 2.9%, or 3.8% excluding currency. Operating profit for the Index edged 0.4% higher. Based on continuing operations, operating margin slipped 70 […]

As the analytical instrument and lab product industry grows, so do companies’ interest in it. Last year, Ahlstrom and Pentair were among the multimillion-dollar companies that increased their industry presence. Both firms serve a variety of markets based on their core focuses. In the case of Ahlstrom, its focus is fiber-based materials. Pentair’s core focus […]

As next-generation sequencing (NGS) becomes more popular in clinical settings, partnerships are forming to enable the application of this new technology for diagnostic applications. In January, two NGS firms announced partnerships with organizations with backgrounds in molecular diagnostics. Life Technologies announced a partnership with Boston Children’s Hospital (BCH) to establish Claritas Genomics, which will develop […]

On January 15, Japan’s Cabinet Office approved a ¥10.3 trillion ($128.8 billion = ¥80 = $1) economic stimulus package. The stimulus package is the second largest in the country’s history, according to Nature, and comes on the heels of Japan’s Liberal Democratic Party resuming power following the December 2012 election. The stimulus package is expected […]

The Society for Laboratory Automation and Screening’s (SLAS) 2013 conference took place January 12–16 at the Gaylord Palms Resort and Convention Center in Orlando, Florida. Orlando was the location of a past conference of the Society for Biomolecular Sciences, one of SLAS’s forebearers (see IBO 2/15/12). Alas, this is the conference’s last stop in Florida […]

Japanese R&D funding increased last fiscal year for the first time in four years. The country’s total R&D spending rose 1.6% in fiscal 2012 (ending March 31, 2012) to ¥17,379 billion ($217.2 billion = ¥80 = $1), according to the annual R&D survey of the Statistics Bureau of Japan’s Ministry of Internal Affairs and Communications. […]

US equity prices flourished to start the year as fears over the fiscal cliff diminished. The US Congress agreed on income tax rates and temporarily resolved the debt ceiling issue. In addition, economic figures continued to advance and corporate earnings were mostly ahead of expectations. Despite a negative 0.1% fourth-quarter US GDP due to lower […]